HIV ESSENTIALS 2008

.

Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women’s Hospital (BWH), where he holds the Bruce A. Beal and Robert L. Beal Distinguished Chair in Infectious Diseases, and Professor of Medicine at Harvard Medical School. Dr. Sax received his MD from Harvard Medical School, completed his residency in Internal Medicine at BWH, then fellowship in Infectious Diseases at Massachusetts General Hospital. He is Editor-in-Chief of Clinical Infectious Diseases, the flagship journal of the Infectious Diseases Society of America, and is Section Editor of HIV/AIDS in UpToDate. He writes HIV and ID Observations for NEJM Journal Watch, and is on the Antiretroviral Guidelines Panel of the International Antiviral Society – USA. Dr. Sax teaches regularly on HIV and infectious diseases locally, nationally, and internationally. In addition to his clinical practice, writing, and teaching, his ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy.

Calvin J. Cohen, MD, MSc, is the Research Director at Community Research Initiative of New England, Clinical Instructor at Harvard Medical School in Boston, Staff Physician at Brigham and Women's Hospital, and Research Director at Harvard Vanguard Medical Associates. He is actively involoved in patient care, teaching, and research. He speaks nationally and internationally and has published numerous articles on HIV/AIDS. His research interests include the study and antiviral treatment of HIV/AIDS and related topics. Dr. Cohen has served as co-chair of the Scientific Advisory Committee of the AmFAR Community-Based Clinical Trial Network and was a co-investigator of the Harvard AIDS Clinical Trial Unit. He is currently a co-principal investigator of the New England AIDS Education and Training Center, and is a co-investigator and member of the Science Planning Council for the Community Program for Clinical Research on AIDS (CPCRA), an NIH-supported network of clinician-researchers. Dr. Cohen is recipient of the Outstanding Physician's Award for his work at Harvard Vanguard Medical Associates; the Harvard Pilgrim Health Care - Robert H. Ebert Teaching Award and the Champions of the Search Award; the Community Recognition Award of the AIDS Action Committee of Massachusetts; the Distinction for Research in Cardiology, Albert Einstein College of Medicine; and the Upjohn Award for Excellence in Medical Training.

Daniel R. Kuritzkes, MD, received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University in 1978, and his MD from Harvard Medical School in 1983. He completed his clinical and research training in internal medicine and infectious disease at Massachusetts General Hospital, and was a visiting scientist at the Whitehead Institute for Biomedical Research before joining the faculty at the University of Colorado Health Sciences Center in 1990. Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is currently Professor of Medicine and Director of AIDS Research, Brigham & Women’s Hospital. Dr. Kuritzkes has written widely on antiretroviral therapy and on the problem of drug resistance in HIV-1 infection. He currently serves as Principal Investigator and Chair of the AIDS Clinical Trials Group Executive Committee. Dr. Kuritzkes also is an Associate Editor of the Journal of Infectious Diseases. His research interests focus on antiretroviral therapy and drug resistance.